生命科学资讯

UK-US biotech investor Epidarex raises $145M for fourth fund

IRA drug pricing petitions pile up at the Supreme Court

Ex-CytoDyn CEO sentenced to 30 months for pump-and-dump scheme

Catalent plans to close Belgium cell therapy site

Sarepta touts three-year Duchenne gene therapy data after patient deaths

Genyro licences DNA builder from Caltech; Dizal targets Hong Kong listing

UK medicines agency seized 20M illegal drugs last year, including GLP-1s

Genmab halts enrollment for cancer drug from ProfoundBio buyout

First-movers respond to herding; BioMarin vets start new biotech; GSK buys RAPT Therapeutics; and more

Novo's Wegovy pill off to a solid start after just two weeks on market

EU kicks off one-year pilot to expedite multinational trials

ACIP members depict diverging goals after schedule change

F2G CEO outlines biotech's FDA resubmission plans, funding and expansion

Sanofi's Phase 3 eczema data cloud hopes for potential immunology blockbuster

Lilly was the only pharma bidder for Ventyx

Insurance CEOs defend their businesses at House hearing

Former FDA deputies land at Lilly, AbbVie; Italy's Angelini has a new CEO

High court picked Hikma’s ‘skinny label’ fight after letting the issue ‘percolate’

Drugmakers spent less on Washington lobbying in 2025's final quarter

Corcept's drug extends patients' lives in key ovarian cancer study